Evidence map›Paper›PMID 42840397›Full record

ArticleJMA journal2026

High-Cost Medical Expense Benefit System in Japanese Universal Health Coverage.

Takaaki Konishi, Kimiko Hirata, Mio Nakata, Mio Adachi, Keita Sasaki, Sumito Saeki, Naomi Sakurai, Yuko Tanabe, Eriko Tokunaga, Tsuguo Iwatani

Abstract read
In one paragraph

Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takaaki KonishiDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
Kimiko HirataDepartment of Radiation Oncology, Osaka Red Cross Hospital, Osaka, Japan.
Mio NakataDepartment of Radiation Oncology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Mio AdachiDepartment of Breast Surgery, Moriyama Memorial Hospital, Tokyo, Japan.
Keita SasakiJapan Clinical Oncology Group Data Center/Operation Office, National Cancer Center Hospital, Tokyo, Japan.
Sumito SaekiBreast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Naomi SakuraiCancer Survivors Recruiting Project, General Incorporated Association, Tokyo, Japan.
Yuko TanabeDepartment of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
Eriko TokunagaDepartment of Breast Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan.
Tsuguo IwataniDepartment of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the citizens of Japan have universal health coverage, the out-of-pocket expenses can still be exorbitant. In 1973, the High-Cost Medical Expense Benefit System was implemented to reduce this financial strain. The system was initially reimbursement based and later evolved into an in-kind benefit model, reducing upfront payments through prior applications or Individual Number Card use. The system permits expenses to be combined among household members; when several high costs have accrued, future monthly ceilings are reduced. Special provisions apply to chronic conditions such as dialysis and hemophilia. In 2024, a governmental proposal to raise the monthly ceiling of the High-Cost Medical Expense Benefit System, which was established to prevent individuals from incurring catastrophic health expenditures, faced criticism for excluding patient feedback. The government subsequently withdrew the proposal and formed a committee to discuss future reforms focusing on sustainability, intergenerational equity, and effective benefit delivery. The High-Cost Medical Expense Benefit System remains essential for ensuring access to advanced care without compromising patients' daily lives.

Indexed as

catastrophic illnesscost sharinghealth expendituresinsuranceuniversal coverage

Identifiers

PMID42840397
PMCPMC13639649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.